The Ministry of Health and Welfare (MOHW) has conducted an on-site inspection on January 7, 2022 and approved the application of human organ storage facility by UnicoCell.
UnicoCell's business is centered on regenerative medicine. We focus on researching and developing stem cells and its derived technology for medical applications, with the goal of advancing human health and improving quality of life.
Our Gold Award new stem cell investigational product ELIXCYTE® has been tested on clinical trials for degenerative knee osteoarthritis (Phase I/II clinical trial completed) and chronic kidney disease (Phase I/II clinical trial).
Our facility and quality system have been certified by the Ministry of Health and Welfare of Taiwan as a GTP laboratory, by PMDA of Japan as an Overseas Cell Processing Center (CPC), and by TAF ISO 17025 as a qualified test laboratory.